| 000 | 01462 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513061240.0 | ||
| 264 | 0 | _c19930701 | |
| 008 | 199307s 0 0 eng d | ||
| 022 | _a0887-6924 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMarie, J P | |
| 245 | 0 | 0 |
_aCyclosporin A as a modifier agent in the salvage treatment of acute leukemia (AL). _h[electronic resource] |
| 260 |
_bLeukemia _cJun 1993 |
||
| 300 |
_a821-4 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily B, Member 1 |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aCarrier Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCyclosporine _xadministration & dosage |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMitoxantrone _xadministration & dosage |
| 700 | 1 | _aBastie, J N | |
| 700 | 1 | _aColoma, F | |
| 700 | 1 | _aFaussat Suberville, A M | |
| 700 | 1 | _aDelmer, A | |
| 700 | 1 | _aRio, B | |
| 700 | 1 | _aDelmas-Marsalet, B | |
| 700 | 1 | _aLeroux, G | |
| 700 | 1 | _aCasassus, P | |
| 700 | 1 | _aBaumelou, E | |
| 773 | 0 |
_tLeukemia _gvol. 7 _gno. 6 _gp. 821-4 |
|
| 999 |
_c8098458 _d8098458 |
||